Publication | Closed Access

PS-078-A phase 1b evaluation of HepTcell HBV-specific immunotherapy in nuc-controlled, eAg negative chronic HBV infection

Viral PersistenceViral HepatitisImmunologyHepatitis BHepatitisVirologyHeptcell Hbv-specific ImmunotherapyPs-078-a Phase 1BAntiviral ResponseChronic Viral InfectionImmunotherapyMedicine